A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 44 shares of BIIB stock, worth $7,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 14 214.29%
Holding current value
$7,646
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$189.07 - $236.8 $5,672 - $7,104
30 Added 214.29%
44 $8,000
Q2 2024

Jul 30, 2024

BUY
$190.52 - $236.72 $190 - $236
1 Added 7.69%
14 $3,000
Q1 2024

May 06, 2024

SELL
$212.02 - $267.71 $424 - $535
-2 Reduced 13.33%
13 $2,000
Q4 2023

May 06, 2024

BUY
$222.59 - $267.94 $445 - $535
2 Added 15.38%
15 $3.88 Million
Q4 2023

Feb 05, 2024

BUY
$222.59 - $267.94 $3,338 - $4,019
15 New
15 $3.88 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.